| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/14/2004 | CN1511860A Poly glycol long chain fatty alkyl maleimide derivative and its medicinal combination |
| 07/14/2004 | CN1511828A Sufonic aniline derivatives and their medicinal use |
| 07/14/2004 | CN1511589A Biological compactable medicine carrier and its preparing method |
| 07/14/2004 | CN1511532A Medical composition |
| 07/14/2004 | CN1157229C Permanent-magnet colloid for plastic self-viscose magnetcally osmosizing ointment and its preparing process |
| 07/14/2004 | CN1157228C Method for the production of tablets by pressing and tablets produced by the method |
| 07/14/2004 | CN1157227C Use of low molecular weight amino alcohols in ophthalmic compositions |
| 07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 07/13/2004 | US6762267 Adjusting bulk density; compact tableting |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
| 07/13/2004 | US6762030 Complexing; immunoassay, immunotherapy |
| 07/13/2004 | US6761914 And an antigen that is preferably a recombinant fusion protein; from seeds from oilseed crops, such as soybean, rapeseed, sunflower and palm |
| 07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
| 07/13/2004 | US6761908 Mixture of acid insoluble fractions each having a different molecular weight; decomposition of calfskin with variable alkalinity and time; bioadhesives; wound healing |
| 07/13/2004 | US6761904 Pharmaceutical kit comprising midodrine as active drug substance |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761879 Titanium derived compounds, preparation and use thereof |
| 07/13/2004 | CA2301267C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 07/13/2004 | CA2260143C Anthelmintic formulations |
| 07/13/2004 | CA2259270C Pharmaceutical preparation containing nimesulide for oral administration |
| 07/13/2004 | CA2238040C Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 07/13/2004 | CA2202913C Antibody reagent for detecting dissecting aortic aneurysm and uses thereof |
| 07/13/2004 | CA2137748C Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/08/2004 | WO2004056877A1 Mixed esters of hyaluronic acid with retinoic and butyric acids |
| 07/08/2004 | WO2004056858A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056386A2 Nucleic acids involved in blood-brain barrier control |
| 07/08/2004 | WO2004056356A1 Oil-acid emulsion and use thereof |
| 07/08/2004 | WO2004056338A2 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 07/08/2004 | WO2004056323A2 Method of treating angiogenic tissue growth |
| 07/08/2004 | WO2004056311A2 Stimuli-responsive systems for controlled drug delivery |
| 07/08/2004 | WO2004056216A1 Method of inhibiting water content variation of composition and use thereof |
| 07/08/2004 | WO2004045491A3 Targeted double stranded rna mediated cell killing |
| 07/08/2004 | WO2004043432A3 Controlled release depot formulations |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
| 07/08/2004 | WO2004035022A3 Prepolymeric materials for site specific delivery to the body |
| 07/08/2004 | WO2004031221A9 Tumor targeting agents and uses thereof |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004024128A3 Modified release ketoprofen dosage form |
| 07/08/2004 | WO2004018010A3 Methods of drug delivery using sulphated chitinous polymers |
| 07/08/2004 | WO2004014322A3 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2003092625A3 Carvedilol formulations |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003069306A3 Protein carrier system for therapeutic oligonucleotides |
| 07/08/2004 | WO2003046204A8 Humanized collagen antibodies and related methods |
| 07/08/2004 | WO2003020245A8 Residual solvent extraction method and microparticles produced thereby |
| 07/08/2004 | US20040133013 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 07/08/2004 | US20040132989 Enhancing purity of lactose via demineralization and alcohol precipitation; infant dairy product; veterinary medicine |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132981 modified ligands that bind irreversibly to their cognate receptors; assay for investigating protein function and as drugs for more effectively inhibiting or stimulating cognate receptor function |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132904 Overcoating medical equipment with nitrosylated cyclodextrin |
| 07/08/2004 | US20040132823 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/08/2004 | US20040132814 Pharmaceutical compositions |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132798 containing a benzonitrile group and N-substituted with a tert-butylcarbonylmethyl- or a tert-butyloxycarbonylaminoethyl- group; particularly in a gelling polymer matrix to form modified release composition |
| 07/08/2004 | US20040132756 incorporating tartaric acid in a solid preparation having a high content of a quinolone compound, particularly sitafloxacin; reduced in fluctuations of oral absorption |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132707 Bactericides, especially gramnegative bacteria; side effect reduction |
| 07/08/2004 | US20040132704 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 07/08/2004 | US20040132700 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial madrix adhesion such as asthma cystic fibrosis and influenza |
| 07/08/2004 | US20040132692 A freeze drying mixture comprising an epothilone and a cyclodextrin; antiproliferative agent, anticarcinogenic agent; cancer, psoriasis, restenosis, multiple sclerosis, rheumatoid arthritis, atherosclerosis; side effect reduction |
| 07/08/2004 | US20040132690 Gel based on chitosan and lactic acid; acidity; dosage form suppository or vaginal tablet; prevention and treatment of vaginal Infections, restoring the physiological lactobacilli flora |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132676 Polynucleotide formulation for enhanced intracellular transfer |
| 07/08/2004 | US20040132656 Blood-coagulation factor VIII (or antihemophilic factor) containing trehalose stabilizer in absence of albumin; reconstitution with water |
| 07/08/2004 | US20040132654 Increased content of high molecular weight multimers; hemophilia and blood disorder treatment |
| 07/08/2004 | US20040132653 Lyophilized composition of bone morphogenetic factor human MP52 |
| 07/08/2004 | US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 07/08/2004 | US20040132188 Mixture comprising modified peptides for use as facilatory tool in gene and protein transfer into cells; gene therapy; drug delivery |
| 07/08/2004 | US20040132143 using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure with a targeted size |
| 07/08/2004 | US20040132010 Immunogen |
| 07/08/2004 | US20040131733 solubilisation of lycopene in this supercritical fluid and to separate the lycopene concentrate by depressurisation carried out at pressures below 10 MPa to produce an oleoresin |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131698 Methods of treating conditions using metal-containing materials |
| 07/08/2004 | US20040131693 Topical applying |
| 07/08/2004 | US20040131692 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 07/08/2004 | US20040131691 Forming oil in water emulsion in presence of surfactants; heating, cooling; encapsulation oil drops |
| 07/08/2004 | US20040131687 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 07/08/2004 | US20040131673 Manufacturing dissolvable dosage forms |
| 07/08/2004 | US20040131668 Two-part capsule to accept pharmaceutical preparations for powder inhalers |
| 07/08/2004 | US20040131666 Liposome encapsulating active materials |
| 07/08/2004 | US20040131665 Topical anesthetic formulation |
| 07/08/2004 | US20040131658 Identification of diet-regulated disease-associated genes |
| 07/08/2004 | US20040131650 Mixture containing viral, bacteria, parasitic antigen |
| 07/08/2004 | US20040131646 Gel delivery vehicles for anticellular proliferative agents |
| 07/08/2004 | US20040131641 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 07/08/2004 | US20040131638 Novel composition |
| 07/08/2004 | US20040131626 Administering a genetic engineered polypeptide |
| 07/08/2004 | US20040131623 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/08/2004 | US20040131604 Methods for inhibiting viral replication in vivo |
| 07/08/2004 | US20040131590 Anticancer agents |
| 07/08/2004 | US20040131586 Stability; bioavailability |